SCHEMBL6982496

SCHEMBL6982496

CN(C)CC(=C=O)c1cc(Cl)sc1Cl

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.45
DAO P14920 1/20 0.44
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
MAPT P10636 4/20 0.39
HPGD P15428 2/20 0.39
KDM4E B2RXH2 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
RAB9A P51151 4/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
NPC1 O15118 1/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
GPR55 Q9Y2T6 1/20 0.36
MAPK1 P28482 2/20 0.35
HTT P42858 1/20 0.35
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3411109 0.73 POLB (0.44) MAPTHPGDKDM4EHTTALDH1A1
SCHEMBL5185754 0.72 MAPK1 (0.48) GSK3BDAOMAOAMAOBMAPT
SCHEMBL6970001 0.72 CYP2C9 (0.34) GSK3BMAPTRAB9ANPC1KMT2A
SCHEMBL5759364 0.69 TDP1 (0.33)
SCHEMBL27400470 0.66 GSK3B (0.46) GSK3BDAOMAOAMAOBMAPT
SCHEMBL3411071 0.66 BCL2L1 (0.42) GSK3BMAOAMAOBMAPTHPGD
SCHEMBL1651982 0.66 LMNA (0.47) HPGDL3MBTL1SMN1; SMN2NPC1KMT2A
SCHEMBL542159 0.65 DAO (0.65) GSK3BDAOMAOAMAOBMAPT
SCHEMBL3605168 0.65 FFAR1 (0.34) MAPTL3MBTL1ALDH1A1
SCHEMBL10512352 0.65 GSK3B (0.69) GSK3BDAOMAOAMAOBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1274705-A1 2-SUBSTITUTED 4-HETEROARYL-PYRIMIDINES AND THEIR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS Cyclacel Limited (GB) 2003-01-15 EP disclosed
WO-2001072745-A1 2-SUBSTITUTED 4-HETEROARYL-PYRIMIDINES AND THEIR USE IN THE TREATMETN OF PROLIFERATIVE DISORDERS CYCLACEL LIMITED (GB) 2001-10-04 WO disclosed